{"id":970,"date":"1998-11-01T12:04:00","date_gmt":"1998-11-01T11:04:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1998\/leserbrief-ergaenzungen-zur-pharmakokinetik-und-wirksamkeit-von-trapidil"},"modified":"1998-11-01T12:04:00","modified_gmt":"1998-11-01T11:04:00","slug":"leserbrief-ergaenzungen-zur-pharmakokinetik-und-wirksamkeit-von-trapidil","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/1998\/leserbrief-ergaenzungen-zur-pharmakokinetik-und-wirksamkeit-von-trapidil","title":{"rendered":"Leserbrief: Erg\u00e4nzungen zur Pharmakokinetik und Wirksamkeit von Trapidil"},"content":{"rendered":"<p>Frau Dr. P.A.T. aus Wuppertal schreibt: >> In der Kleinen Mitteilung zu Trapidil (AMB 1998, 32, 59) werden einige pharmakologische Eigenschaften des Trapidils aufgef\u00fchrt, wie z.B. die Hemmung des Platelet derived growth factor. Hinzuzuf\u00fcgen ist, da\u00df alle diese Befunde in vitro nachgewiesen wurden; ex vivo gelang bislang kein Nachweis, da\u00df Trapidil etwa im Ausma\u00df von [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frau Dr. P.A.T. aus Wuppertal schreibt: >> In der Kleinen Mitteilung zu Trapidil (AMB 1998, 32, 59) werden einige pharmakologische Eigenschaften des Trapidils aufgef\u00fchrt, wie z.B. die Hemmung des Platelet derived growth factor. Hinzuzuf\u00fcgen ist, da\u00df alle diese Befunde in vitro nachgewiesen wurden; ex vivo gelang bislang kein Nachweis, da\u00df Trapidil etwa im Ausma\u00df von [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[74,77,76,1590,85,86,83,84,87,79,2386,2387],"class_list":["post-970","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-acetylsalicylsaeure","tag-ass","tag-azetylsalizylsaeure","tag-caprie-studie","tag-koronarangiografie","tag-koronarangiographie","tag-pci","tag-perkutane-koronarintervention","tag-perkutane-transluminale-koronare-angioplastie","tag-ptca","tag-starc-studie","tag-trapidil"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=970"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/970\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}